Pre-order Enquiry
Request Free Sample
Global Valacyclovir Market Research Report 2022
SKU ID : QYR-21414748 | Publishing Date : 03-Aug-2022 | No. of pages : 121
Valacyclovir
Due to the COVID-19 pandemic, the global Valacyclovir market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Valacyclovir market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Valacyclovir landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Tablets accounting for % of the Valacyclovir global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Herpes Zoster Virus segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Valacyclovir include GSK, Mylan Pharmaceuticals, Cobalt Laboratories (Allergan), Sorres Pharma, Sivem Pharmaceuticals, Remedy Repack, Apotex Corporation, Auro Pharma and Biomed Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Valacyclovir in 2021.
This report focuses on Valacyclovir volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Valacyclovir market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Valacyclovir Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Tablets
Capsule
Granules
Segment by Application
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GSK
Mylan Pharmaceuticals
Cobalt Laboratories (Allergan)
Sorres Pharma
Sivem Pharmaceuticals
Remedy Repack
Apotex Corporation
Auro Pharma
Biomed Pharma
PLIVA
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Livzon Pharmaceutical Group
Beijing Shuanglu Pharmaceutical
Sichuan Mingxin Pharmaceutical
Sichuan Baili Pharmaceutical
Sichuan Kelun Pharmaceutical
Ansi Pharmaceutical
Yichang Dongyangguang Changjiang Pharmaceutical
Shandong New Era Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Baike Pharmaceutical
Chengdu Beite Pharmaceutical
Kunming Yuanrui Pharmaceutical
Yongxin Pharmaceutical Industry
Hubei Huashitong Qianlong Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Zhuhai Rundu Pharmaceutical
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Due to the COVID-19 pandemic, the global Valacyclovir market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Valacyclovir market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Valacyclovir landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Tablets accounting for % of the Valacyclovir global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Herpes Zoster Virus segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Valacyclovir include GSK, Mylan Pharmaceuticals, Cobalt Laboratories (Allergan), Sorres Pharma, Sivem Pharmaceuticals, Remedy Repack, Apotex Corporation, Auro Pharma and Biomed Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Valacyclovir in 2021.
This report focuses on Valacyclovir volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Valacyclovir market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Valacyclovir Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Tablets
Capsule
Granules
Segment by Application
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GSK
Mylan Pharmaceuticals
Cobalt Laboratories (Allergan)
Sorres Pharma
Sivem Pharmaceuticals
Remedy Repack
Apotex Corporation
Auro Pharma
Biomed Pharma
PLIVA
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Livzon Pharmaceutical Group
Beijing Shuanglu Pharmaceutical
Sichuan Mingxin Pharmaceutical
Sichuan Baili Pharmaceutical
Sichuan Kelun Pharmaceutical
Ansi Pharmaceutical
Yichang Dongyangguang Changjiang Pharmaceutical
Shandong New Era Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Baike Pharmaceutical
Chengdu Beite Pharmaceutical
Kunming Yuanrui Pharmaceutical
Yongxin Pharmaceutical Industry
Hubei Huashitong Qianlong Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Zhuhai Rundu Pharmaceutical
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
